Roest A y col. BMC Emergency Medicine 2015, 15:29 doi:10.1186/s12873-015-0056-z
"The aim of our study was to investigate the predictive value and feasibility of the abbMEDS and CURB-65 in internal medicine patients presenting with sepsis at the ED. In addition, we aimed to assess the relationship between the three risk categories defined by both scores and two clinical decisions, i.e. empirical antibiotic treatment and clinical disposition.
Conclusions
Both the abbMEDS and CURB-65 are good predictors of 28-day mortality in sepsis patients and are very feasible at the ED. The abbMEDS is well calibrated. A new finding is that the abbMEDS matches current clinical decisions in sepsis patients concerning antibiotic treatment and clinical disposition well, while this is less the case for the CURB-65. To improve the standard of care of sepsis, further research on the ability of the abbMEDS to provide support in clinical decisions in sepsis patients at the ED must be performed."
http://www.biomedcentral.com/1471-227X/15/29
*
Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med. 2003 Mar;31(3):670-5. »PubMed